• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 課題ページに戻る

2022 年度 実施状況報告書

コメ由来のモミラクトンや、天然化合物のバイオアベイラビリティと抗がん作用の評価

研究課題

研究課題/領域番号 21K14818
研究機関広島大学

研究代表者

NGUYEN VANQUAN  広島大学, 先進理工系科学研究科(国), 助教 (90883033)

研究期間 (年度) 2021-04-01 – 2025-03-31
キーワードmomilactones / anti-blood cancer / bioaccessibility / in vitro digestion
研究実績の概要

The cytotoxic mechanism of momilactones A (MA) and B (MB) against blood cancer cell lines including acute promyelocytic leukemia and multiple myeloma were clarified. Of which, According to MTT results, MB and the mixture MAB (1:1, w/w) show a substantial inhibition on the cell viability of HL-60 and U266, with IC50 ranging from 4.49 to 5.59 uM. Besides, MB and MAB at 5 uM inhibit HL-60 cells through the regulations of relevant proteins to apoptosis-inducing factors (p-38, BCL-2, and caspase-3) and cell cycle arrest at G2 phase (p-38, CDK1, and cyclin B1). Meanwhile, these compounds enhance U266 apoptosis by altering p-38, BCL-2, and caspase-3 signaling pathways. Significantly, momilactones exhibit a minor effect on a non-cancerous cell line (MeT-5A), implying that they are promising candidates for developing novel anti-APL and anti-MM medicines. The results were published on Cancers. In addition, the effects of in vitro digestion on anti-blood cancer and bioaccessibility of MA and MB were investigated. Results reveal that the cytotoxic activities of MB and MAB were dramatically decreased. In addtition, the bioaccessibility of momilactones was significantly reduced (from 28.44% to 75.14%) which was strongly correlated with their decreased cytotoxicity under digestion. The findings were presented at the 2023 Annual Meeting of the Japan Society for Bioscience, Biotechnology, and Agrochemistry (日本農芸化学会2023年度大会), Online meeting, March 2023.

現在までの達成度 (区分)
現在までの達成度 (区分)

2: おおむね順調に進展している

理由

- Thanks to the enthusiastic support and collaboration with the Hematology Lab led by Prof. Dr. Takami Akiyoshi at Aichi Medical University, we could successfully clarify cytototic mechanisms of momilactone on blood cancer cells.
- With a good preparation of in vitro digestion protocol, we could screen the effect of in vitro digestion model on the accessibility and cytotoxicity of momilactones.
- The isolation and purification of other new active compounds took longer time than we expected due to the operation of column chromatogram and purification process.

今後の研究の推進方策

- To complete purification of other bioactive compounds and checking their anticancer properties in a combination with momilactones and other synthetically commercial drugs.
- To evaluate and confirm the anticancer properties of the combinations of momilactones and natural compounds from rice based on natural killer cell assays.
- To investigate the contents of momilactones and other anticancer compounds from fermented rice products, in order to find out a potential method for improving accessibility of momilactones.

  • 研究成果

    (2件)

すべて 2023 2022

すべて 雑誌論文 (1件) (うち国際共著 1件) 学会発表 (1件)

  • [雑誌論文] Cytotoxic Mechanism of Momilactones A and B against Acute Promyelocytic Leukemia and Multiple Myeloma Cell Lines2022

    • 著者名/発表者名
      Anh La Hoang、Lam Vu Quang、Takami Akiyoshi、Khanh Tran Dang、Quan Nguyen Van、Xuan Tran Dang
    • 雑誌名

      Cancers

      巻: 14 ページ: 4848~4848

    • DOI

      10.3390/cancers14194848

    • 国際共著
  • [学会発表] Effects of in vitro digestion on momilactones and their anti-blood cancer activity2023

    • 著者名/発表者名
      La Hoang Anh
    • 学会等名
      日本農芸化学会2023年度大会, Online meeting, March 2023

URL: 

公開日: 2023-12-25  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi